Resonance Health
Follow
Get notifications in MyBN when activity occurs.
Resonance Health, a healthcare company, engages in the development and commercialization of magnetic resonance imaging (MRI) related technology primarily in Australia.
The company’s core product is FerriScan, a non-invasive liver diagnostic product used for the measurement of iron levels in the liver. Its FerriScan also provides a range of value added services for clinical trials using imaging end points.
The company is also developing imaging tools for the non-invasive assessment of liver fat and liver fibrosis to address clinical need for patients with fatty liver disease and viral hepatitis.
Contact Details
Suite 2, Ground Floor, 141 Burswood Road, BURSWOOD WA 6100
08 9286 5300
Lists and Charts
Public Companies - Industrial WA list sponsored by
Technology Companies list sponsored by
Share Price
Closing price for the last 90 trading days
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 114th |  | Resonance Health | $4.0m |
| 124th |  | Queste Communications | $3.1m |
| 125th |  | Motio | $3.0m |
| 127th | | Emyria | $2.9m |
| 128th | | DW8 | $2.8m |
209 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Total Shareholder Return as at 29/04/22
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 219th | Queste Communications | 75% | 1% |
| 363rd | Emyria | 42% | |
| 1479th | Resonance Health | -38% | 43% |
| 1504th | Motio | -40% | -8% |
| 1888th | DW8 | -80% | 19% |
1811 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Company Activity
| NEWS: Tagged in Resonance Health looks to China | 27 Jan 2022 |
| NEW ROLE: Sofie De Meyer, Innovation Manager | 11 Jan 2022 |
| NEWS: Tagged in Appointments November 26, 2021 | 25 Nov 2021 |
| NEW ROLE: John Olynyk, Chief Medical Officer | 24 Nov 2021 |
| NEW ROLE: AS Pervez, | 15 Oct 2021 |
| NEWS: Tagged in Board Moves June 28, 2021 | 28 Jun 2021 |
| NEWS: Tagged in Researchers eye health benefit from AI | 14 Jun 2021 |
| NEWS: Tagged in Board Moves June 4, 2021 | 04 Jun 2021 |
| NEW ROLE: Mitchell Wells, Executive Director, Managing Director | 04 Jun 2021 |
| NEWS: Tagged in Board Moves April 8, 2021 | 08 Apr 2021 |
